158 related articles for article (PubMed ID: 16075919)
1. Graves' ophthalmopathy: search for shared autoantigen(s) continues.
Bartalena L
J Endocrinol Invest; 2005 May; 28(5):396-7. PubMed ID: 16075919
[No Abstract] [Full Text] [Related]
2. Has the target autoantigen for Graves' ophthalmopathy been found?
McGregor AM
Lancet; 1998 Aug; 352(9128):595-6. PubMed ID: 9746018
[No Abstract] [Full Text] [Related]
3. Detection of the novel autoantibody (anti-UACA antibody) in patients with Graves' disease.
Ohkura T; Taniguchi S; Yamada K; Nishio N; Okamura T; Yoshida A; Kamijou K; Fukata S; Kuma K; Inoue Y; Hisatome I; Senju S; Nishimura Y; Shigemasa C
Biochem Biophys Res Commun; 2004 Aug; 321(2):432-40. PubMed ID: 15358194
[TBL] [Abstract][Full Text] [Related]
4. Tissue specificity and serologic reactivity of an autoantigen associated with autoimmune thyroid disease.
Ross PV; Koenig RJ; Arscott P; Ludgate M; Waier M; Nelson CC; Kaplan MM; Baker JR
J Clin Endocrinol Metab; 1993 Aug; 77(2):433-8. PubMed ID: 8345048
[TBL] [Abstract][Full Text] [Related]
5. Surgical management of Graves' ophthalmopathy.
Austin MW; Atta HR
Br J Hosp Med; 1992 Nov 18-Dec 1; 48(10):644-9. PubMed ID: 1458273
[TBL] [Abstract][Full Text] [Related]
6. Graves' ophthalmopathy.
Wall JR; Henderson J; Strakosch CR; Joyner DM
Can Med Assoc J; 1981 Apr; 124(7):855-62, 866. PubMed ID: 7011529
[TBL] [Abstract][Full Text] [Related]
7. The putative role of fibroblasts in the pathogenesis of Graves' disease: evidence for the involvement of the insulin-like growth factor-1 receptor in fibroblast activation.
Smith TJ
Autoimmunity; 2003; 36(6-7):409-15. PubMed ID: 14669949
[TBL] [Abstract][Full Text] [Related]
8. Thyrotropin receptor expression in orbital adipose/connective tissues from patients with thyroid-associated ophthalmopathy.
Bahn RS
Thyroid; 2002 Mar; 12(3):193-5. PubMed ID: 11952038
[TBL] [Abstract][Full Text] [Related]
9. Thyroid-stimulating antibody is related to Graves' ophthalmopathy, but thyrotropin-binding inhibitor immunoglobulin is related to hyperthyroidism in patients with Graves' disease.
Noh JY; Hamada N; Inoue Y; Abe Y; Ito K; Ito K
Thyroid; 2000 Sep; 10(9):809-13. PubMed ID: 11041459
[TBL] [Abstract][Full Text] [Related]
10. Should Graves' disease be considered a collagen disorder of the thyroid, skeletal muscle and connective tissue?
Kiljanski J; Nebes V; Stachura I; Kennerdell JS; Wall JR
Horm Metab Res; 1995 Dec; 27(12):528-32. PubMed ID: 8750780
[TBL] [Abstract][Full Text] [Related]
11. Pathogenesis and treatment of the ophthalmopathy associated with Graves' disease.
Velkeniers B; Salu P
Bull Soc Belge Ophtalmol; 1992; 245():9-14. PubMed ID: 1344754
[TBL] [Abstract][Full Text] [Related]
12. [Thyroid-associated ophthalmopathy: physiopathology, endocrine status].
Teissier MP; Lopez S
J Fr Ophtalmol; 2004 Sep; 27(7):806-9. PubMed ID: 15499281
[TBL] [Abstract][Full Text] [Related]
13. Precipitation of the thyrotropin receptor and identification of thyroid autoantigens using Graves' disease immunoglobulins.
Heyma P; Harrison LC
J Clin Invest; 1984 Sep; 74(3):1090-7. PubMed ID: 6088581
[TBL] [Abstract][Full Text] [Related]
14. Effect of abnormal thyroid function on the severity of Graves' ophthalmopathy.
Prummel MF; Wiersinga WM; Mourits MP; Koornneef L; Berghout A; van der Gaag R
Arch Intern Med; 1990 May; 150(5):1098-101. PubMed ID: 1691908
[TBL] [Abstract][Full Text] [Related]
15. Suppressed natural killer cell activity in patients with euthyroid Graves' ophthalmopathy.
Pedersen BK; Perrild H; Feldt-Rasmussen U; Christensen T; Klarlund K; Hansen JM
Autoimmunity; 1989; 2(4):291-8. PubMed ID: 2491612
[TBL] [Abstract][Full Text] [Related]
16. Association of thyrotrophin receptor antibodies with the clinical features of Graves' ophthalmopathy.
Gerding MN; van der Meer JW; Broenink M; Bakker O; Wiersinga WM; Prummel MF
Clin Endocrinol (Oxf); 2000 Mar; 52(3):267-71. PubMed ID: 10718823
[TBL] [Abstract][Full Text] [Related]
17. Pathogenesis of Graves' ophthalmopathy--current understanding.
Wiersinga WM; Prummel MF
J Clin Endocrinol Metab; 2001 Feb; 86(2):501-3. PubMed ID: 11157999
[No Abstract] [Full Text] [Related]
18. Graves' ophthalmopathy and dermopathy. Preface.
Wiersinga WM
Best Pract Res Clin Endocrinol Metab; 2012 Jun; 26(3):227. PubMed ID: 22632360
[No Abstract] [Full Text] [Related]
19. Toward better models of hyperthyroid Graves' disease.
Dağdelen S; Kong YC; Banga JP
Endocrinol Metab Clin North Am; 2009 Jun; 38(2):343-54, viii. PubMed ID: 19328415
[TBL] [Abstract][Full Text] [Related]
20. Graves' dermopathy and acropachy are markers of severe Graves' ophthalmopathy.
Fatourechi V; Bartley GB; Eghbali-Fatourechi GZ; Powell CC; Ahmed DD; Garrity JA
Thyroid; 2003 Dec; 13(12):1141-4. PubMed ID: 14751035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
